Ophthalmic Formulation

Thomas Millar; Burkhardt Schuett

Ophthalmic Formulation

Thomas Millar (Inventor)
, Burkhardt Schuett (Inventor)

Research output: Patent

Abstract

Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R.sup.1 is a linear or branched C.sub.9-C.sub.33 alkyl or a linear or branched C.sub.9-C.sub.33 alkenyl with 1 to 4 double bonds; R.sup.2 is a linear or branched C.sub.9-C.sub.19 alkyl or a linear or branched C.sub.9-C.sub.19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.

Original language	English
Patent number	US20200190015A1
Filing date	18/07/19
Publication status	Published - 2020

Access to Document

https://patents.google.com/patent/US20200190015A1/en?oq=US+2020%2f0190015+A1

Cite this

@misc{7d5eb3055d7945c5a7e3812785a9c04e,

title = "Ophthalmic Formulation",

abstract = "Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R.sup.1 is a linear or branched C.sub.9-C.sub.33 alkyl or a linear or branched C.sub.9-C.sub.33 alkenyl with 1 to 4 double bonds; R.sup.2 is a linear or branched C.sub.9-C.sub.19 alkyl or a linear or branched C.sub.9-C.sub.19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.",

author = "Thomas Millar and Burkhardt Schuett",

year = "2020",

language = "English",

publisher = "US Patent \& Trademark Office",

type = "Patent",

note = "US20200190015A1",

}

TY - PAT

T1 - Ophthalmic Formulation

AU - Millar, Thomas

AU - Schuett, Burkhardt

PY - 2020

Y1 - 2020

N2 - Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R.sup.1 is a linear or branched C.sub.9-C.sub.33 alkyl or a linear or branched C.sub.9-C.sub.33 alkenyl with 1 to 4 double bonds; R.sup.2 is a linear or branched C.sub.9-C.sub.19 alkyl or a linear or branched C.sub.9-C.sub.19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.

AB - Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R.sup.1 is a linear or branched C.sub.9-C.sub.33 alkyl or a linear or branched C.sub.9-C.sub.33 alkenyl with 1 to 4 double bonds; R.sup.2 is a linear or branched C.sub.9-C.sub.19 alkyl or a linear or branched C.sub.9-C.sub.19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.

M3 - Patent

M1 - US20200190015A1

Y2 - 2019/07/18

PB - US Patent & Trademark Office

ER -

Ophthalmic Formulation

Abstract

Access to Document

Fingerprint

Cite this